Abstract:Background: Despite unclear pathogenesis, previous studies have suggested immune responses may play a pivotal role in the process of Moyamoya disease (MMD), a rare cerebrovascular occlusive disorder. The objective of this study is aimed to explore the change of peripheral Treg/Th17 in MMDpatients and whether the change is associated with pathogenesis of MMD. Methods: In the present study, we collected 26 MMD patients diagnosed by angiography according to the diagnostic criteria of definitive MMD and recruited 32 healthy volunteers. To explore the balance of peripheral Treg/Th17 in MMD patients, lymphocytes in peripheral blood were harvested and flow cytometry was used to measure the percentage of Treg and Th17in CD4+ Tcells, respectively. Meanwhile, relevant cytokines in serum were measured to evaluate the function of Treg and Th17 cells. Results: According to Suzuki’s angiographic staging of moyamoya disease, patients were divided into subgroups of the preliminary-term, medium-term and late-term. Cerebral hemorrhage is thefirstsymptom of onset occuringin half of patients, followed bycerebral ischemia.Our data revealed that both the percentage of Treg and Th17 cells in peripheral blood lymphocytes was increased in MMD patients compared with volunteer group. Meanwhile, the levels of IL-6, IL-10,IL-12, IL-17, TNF-α, VEGF and TGF-β in serum were significantly increased in MMD patients. In this study, the level of HMGB-1, a middle-late period inflammation biomarker, in serum of MMD patients is obviously elevated compared with volunteers. However, the ratio of Treg/Th17 had no significant difference in MMD patients compared to healthy volunteers. Intriguingly, our data revealed that ratio of Treg/Th17 was significantly increased in late-term MMD patients compared with medium-term patients as evidenced by elevated percentage of Treg cells.. In addition, TGF-β level in later-term MMD patients was significantly higher than this in medium-term MMD patients. No difference was observed in the way of onset and gender between two groups. Conclusion: Enhanced peripheral Treg and Th17 in MMD patients suggested that there may be an immunological component in the pathogenesis of MMD. Peripheral Treg may be associated with pathological process of MMD.

Peripheral blood expression impacts mutation penetrance and clinical severity in moyamoya disease

Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213

Identification of Rnf213 As A Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

Abstract TP284: Transcriptome Profiling of Peripheral Blood Mononuclear Cells in Moyamoya Disease

Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients with Moyamoya Disease

RNF213 in moyamoya disease: Genotype–phenotype association and the underlying mechanism

The Genetic Basis of Moyamoya Disease

Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population.

HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K

Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo

RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.

The Susceptibility Pathogenesis of Moyamoya Disease

An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease

Increased abundance of Ruminococcus gnavus in gut microbiota is associated with moyamoya disease and non-moyamoya intracranial large artery disease

RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease

Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213

Abstract 51: Peripheral Regulatory T Cells and Th17 Cells is Associated with Pathogenesis of Moyamoya Disease

Association of rare variants in RNF213 with severe progression of intracranial artery stenosis in quasi-moyamoya disease

Peripheral blood expression impacts mutation penetrance and clinical severity in moyamoya disease

Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G&gt;a variant in RNF213

Identification of Rnf213 As A Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

Abstract TP284: Transcriptome Profiling of Peripheral Blood Mononuclear Cells in Moyamoya Disease

Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients with Moyamoya Disease

RNF213 in moyamoya disease: Genotype–phenotype association and the underlying mechanism

The Genetic Basis of Moyamoya Disease

Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population.

HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K

Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo

RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.

The Susceptibility Pathogenesis of Moyamoya Disease

An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease

Increased abundance of Ruminococcus gnavus in gut microbiota is associated with moyamoya disease and non-moyamoya intracranial large artery disease

RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease

Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213

Abstract 51: Peripheral Regulatory T Cells and Th17 Cells is Associated with Pathogenesis of Moyamoya Disease

Association of rare variants in RNF213 with severe progression of intracranial artery stenosis in quasi-moyamoya disease

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213